Cencora (COR) revenue breakdown
By segment, U.S. Healthcare Solutions is the largest at 91% of fiscal 2025 revenue; International Healthcare Solutions grew fastest, 27% a year over 4 years.
Revenue by segment
Fiscal years, as Cencora reports them in its 10-K filings; fiscal 2025 total $321.3B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Healthcare Solutions | — | — | — | — | — | $202.5B | $212.1B | $234.8B | $265.3B | $291.0B | 91% |
| International Healthcare Solutions | — | — | — | — | — | $11.5B | $26.5B | $27.4B | $28.6B | $30.4B | 9% |
| Pharmaceutical Distribution Services | $141.7B | $147.5B | $161.7B | $172.8B | $182.5B | — | — | — | — | — | — |
| Other | $5.2B | $5.7B | $6.3B | $6.9B | $7.5B | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for COR.
Open COR in InvestinglyQuestions
Where does Cencora make its money?
In fiscal 2025, by segment: U.S. Healthcare Solutions $291.0B, International Healthcare Solutions $30.4B.
From Cencora's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.